Gabriel E. Molina

734 total citations
21 papers, 368 citations indexed

About

Gabriel E. Molina is a scholar working on Oncology, Dermatology and Epidemiology. According to data from OpenAlex, Gabriel E. Molina has authored 21 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Dermatology and 5 papers in Epidemiology. Recurrent topics in Gabriel E. Molina's work include Cancer Immunotherapy and Biomarkers (11 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cutaneous lymphoproliferative disorders research (4 papers). Gabriel E. Molina is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cutaneous lymphoproliferative disorders research (4 papers). Gabriel E. Molina collaborates with scholars based in United States, United Kingdom and Taiwan. Gabriel E. Molina's co-authors include Kerry L. Reynolds, Steven T. Chen, Michael Dougan, Hui Zheng, Ryan J. Sullivan, Riley Fadden, Vikram Deshpande, Girish C. Mohan, Robert Stavert and Kevin Wang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American Academy of Dermatology.

In The Last Decade

Gabriel E. Molina

19 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gabriel E. Molina United States	12	215	77	60	54	43	21	368
Ingolf Franke Germany	11	130 0.6×	99 1.3×	79 1.3×	89 1.6×	62 1.4×	32	362
Helena Collgros Spain	11	126 0.6×	88 1.1×	135 2.3×	46 0.9×	40 0.9×	33	315
I. Botev Germany	7	124 0.6×	91 1.2×	73 1.2×	196 3.6×	108 2.5×	10	381
Alfred A. Chan United States	7	135 0.6×	34 0.4×	18 0.3×	95 1.8×	173 4.0×	19	338
Yasuhiro Horiuchi Japan	12	50 0.2×	62 0.8×	134 2.2×	64 1.2×	35 0.8×	67	382
Sara Viragova Slovakia	9	49 0.2×	99 1.3×	94 1.6×	98 1.8×	51 1.2×	14	297
Valerie R. Yanofsky United States	7	126 0.6×	232 3.0×	130 2.2×	105 1.9×	48 1.1×	10	428
Momodou L. Jammeh United States	7	255 1.2×	52 0.7×	118 2.0×	219 4.1×	96 2.2×	15	627
Jason Wu Australia	9	114 0.5×	217 2.8×	226 3.8×	121 2.2×	37 0.9×	19	390
Jørgen Rønnevig Norway	6	73 0.3×	140 1.8×	137 2.3×	23 0.4×	40 0.9×	11	327

Countries citing papers authored by Gabriel E. Molina

Since Specialization

Citations

This map shows the geographic impact of Gabriel E. Molina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel E. Molina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel E. Molina more than expected).

Fields of papers citing papers by Gabriel E. Molina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriel E. Molina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel E. Molina. The network helps show where Gabriel E. Molina may publish in the future.

Co-authorship network of co-authors of Gabriel E. Molina

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriel E. Molina. A scholar is included among the top collaborators of Gabriel E. Molina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriel E. Molina. Gabriel E. Molina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Durbin, Sienna, Chia‐Yun Wu, Jaclyn LoPiccolo, et al.. (2025). Late-Onset Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy. JAMA Network Open. 8(3). e252668–e252668. 10 indexed citations

Blum, Steven M., Ben Ouyang, Leyre Zubiri, et al.. (2025). Tumor location as a risk factor for severe immune-related adverse events. Journal for ImmunoTherapy of Cancer. 13(5). e011312–e011312.

Durbin, Sienna, et al.. (2023). Frequency of delayed immune-related adverse events (irAEs) in hospitalized patients treated with immune checkpoint inhibitors (ICIs).. Journal of Clinical Oncology. 41(16_suppl). 2652–2652.

Thompson, Leah L., Jordan T. Said, Jaewon Yoon, et al.. (2022). Diagnostic accuracy of general dermatologists and supportive oncodermatologists for biopsied cutaneous immune-related adverse events. Supportive Care in Cancer. 30(10). 7827–7831. 2 indexed citations

Yoon, Jaewon, Jordan T. Said, Leah L. Thompson, et al.. (2021). Medical student perceptions of assessment systems, subjectivity, and variability on introductory dermatology clerkships. International Journal of Women’s Dermatology. 7(3). 323–330. 3 indexed citations

Thompson, Leah L., C. Pan, Michael S. Chang, et al.. (2021). Alemtuzumab, total skin electron beam, and non‐myeloablative allogeneic haematopoietic stem‐cell transplantation in advanced sezary syndrome: a retrospective cohort study. Journal of the European Academy of Dermatology and Venereology. 35(6). e373–e375. 1 indexed citations

Zubiri, Leyre, Gabriel E. Molina, Meghan J. Mooradian, et al.. (2021). Impact of multidisciplinary severe immunotherapy complication service on outcomes for cancer patients receiving immune checkpoint inhibition.. Journal of Clinical Oncology. 39(15_suppl). 2654–2654. 1 indexed citations

Bain, Paul, et al.. (2021). Topical treatments for early-stage mycosis fungoides using Grading Recommendations Assessment, Development and Evaluation (GRADE) criteria: A systematic review. JAAD International. 3. 26–41. 5 indexed citations

Thompson, Leah L., Nira A. Krasnow, Michael S. Chang, et al.. (2021). Patterns of Cutaneous and Noncutaneous Immune-Related Adverse Events Among Patients With Advanced Cancer. JAMA Dermatology. 157(5). 577–577. 34 indexed citations

10.

Seethapathy, Harish, Sophia Zhao, Ian A. Strohbehn, et al.. (2020). Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors. Kidney International Reports. 5(10). 1700–1705. 43 indexed citations

11.

Molina, Gabriel E., Melissa Danesh, Ruth K. Foreman, & Daniela Kroshinsky. (2020). A 78-Year-Old Female with a Diffuse Pruritic Rash and Palmoplantar Desquamation. SHILAP Revista de lepidopterología. 6(4). 241–245. 2 indexed citations

12.

Molina, Gabriel E., Ian M. Allen, Leyre Zubiri, et al.. (2019). Prognostic implications of co-occurring dermatologic and gastrointestinal toxicity from immune checkpoint inhibition therapy for advanced malignancies: A retrospective cohort study. Journal of the American Academy of Dermatology. 82(3). 743–746. 14 indexed citations

13.

Zheng, Hui, Leyre Zubiri, Gabriel E. Molina, et al.. (2019). Colitis after checkpoint blockade: A retrospective cohort study of melanoma patients requiring admission for symptom control. Cancer Medicine. 8(11). 4986–4999. 28 indexed citations

14.

Molina, Gabriel E., Steven T. Chen, Hui Zheng, et al.. (2019). Budesonide treatment for microscopic colitis from immune checkpoint inhibitors. Journal for ImmunoTherapy of Cancer. 7(1). 292–292. 75 indexed citations

15.

Molina, Gabriel E., Sherry H. Yu, & Victor Neel. (2019). Observations Regarding Infection Risk in Lower-Extremity Wound Healing by Second Intention. Dermatologic Surgery. 46(10). 1342–1344. 12 indexed citations

16.

Molina, Gabriel E., Saami Khalifian, Lu Chen, et al.. (2019). Topical Combination of Fluorouracil and Calcipotriene as a Palliative Therapy for Refractory Extramammary Paget Disease. JAMA Dermatology. 155(5). 599–599. 21 indexed citations

17.

Mohan, Girish C., Gabriel E. Molina, & Robert Stavert. (2018). Store and forward teledermatology improves dermatology knowledge among referring primary care providers: A survey-based cohort study. Journal of the American Academy of Dermatology. 79(5). 960–961. 24 indexed citations

18.

Russo, Brian C., Luisa M. Stamm, Matthijs Raaben, et al.. (2016). Intermediate filaments enable pathogen docking to trigger type 3 effector translocation. Nature Microbiology. 1(4). 16025–16025. 39 indexed citations

19.

Prima, Victor, et al.. (2011). Inhibition of LPS toxicity by hepatic argininosuccinate synthase (ASS): Novel roles for ASS in innate immune responses to bacterial infection. International Immunopharmacology. 11(9). 1180–1188. 13 indexed citations

20.

Molina, Gabriel E., et al.. (2011). Anti-LPS Test Strip for the Detection of Food Contaminated with Salmonella and E. coli. Journal of Microbial & Biochemical Technology. 3(2). 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact